This explainer is more than 90 days old. Some of the information might be out of date or no longer relevant. Browse our homepage for up to date content or request information about a specific topic from our team of scientists.
This article has been translated from its original language. Please reach out if you have any feedback on the translation.
SciLine reaches out to our network of scientific experts and poses commonly asked questions about newsworthy topics. Reporters can use these responses in news stories, with attribution to the expert.
SciLine reaches out to our network of scientific experts and poses commonly asked questions about newsworthy topics. Reporters can use these responses in news stories, with attribution to the expert.
In addition to vaccine storage benefits, the major advantage of the Novavax vaccine is its safety. Protein-subunit vaccines are considered the safest form of vaccines, based on a widely used technology. The hepatitis B vaccine is an example of a recombinant protein subunit vaccine. If one reason for someone’s hesitation to get a COVID-19 vaccine is safety, then the Novavax vaccine may be a good alternative. The drawback is that it may not be as effective as the mRNA vaccines against the new variants. Developing new versions of protein-based vaccines against the variants will take more time and effort than altering mRNA vaccines.
The vaccine induces high levels of virus neutralizing antibodies and protective immunity shown in multiple clinical trials and also has an excellent safety profile.